BNET, by Jim Edwards, August 4, 2010, Allergan (AGN) had a great Q2 2010 earnings report: revenues were up 10 percent to $1.2 billion. In terms of Botox, breast implants and tummy tucks the recesssion is well and truly over.
But Allergan did not do this alone. It had help from Hollywood. As CEO David Pyott > Read More